Shanghai Junshi Biosciences Co (FRA:8SJ) Quality Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8SJ Shanghai Junshi Biosciences Co Ltd FRA:8SJ
67 GF Score
Price €1.99
GF Value €3.38
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Shanghai Junshi Biosciences Co Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Shanghai Junshi Biosciences Co Quality Rank Related Terms

FRA:8SJ
67GF Score
Shanghai Junshi Biosciences Co Ltd FRA:8SJ
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shanghai Junshi Biosciences Co (FRA:8SJ) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Junshi Biosciences Co stock appears to be undervalued. The current stock price of €1.99 is trading 41.1% below its estimated GF Value™ of €3.38. GuruFocus considers Shanghai Junshi Biosciences Co to be Significantly Undervalued.

Key valuation signals for FRA:8SJ:

  • Quality Rank:
  • GF Value™: €3.38 vs. price of €1.99 (41.1% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the FRA:8SJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Junshi Biosciences Co Business Description

Address No. 987 Cai Lun Road, Level 4, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN
Shanghai Junshi Biosciences Co Ltd is mainly involved in the discovery, development, and commercialisation of therapeutic drugs. It focuses on the development and commercialization of several kinds of drugs, ranging from monoclonal antibodies to various drug modalities, including small molecules, ADCs, bi-specific or multi-specific antibodies, fusion proteins, nucleic acid drugs, and vaccines, as well as the exploration of next-generation therapies, including those for cancer and autoimmune diseases. The Group's portfolio includes commercialized drugs such as Tuoyi, Junmaikang, Mindewei, and Junshida, as well as products in clinical studies or in the marketing application stage. Geographically, it derives maximum revenue from Mainland China, and the rest from USA, India, and other markets.
67GF Score

Get the complete analysis for FRA:8SJ

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.99
Price
€3.38
GF Value